about
Epidemiological changes in leishmaniasis in Spain according to hospitalization-based records, 1997-2011: raising awareness towards leishmaniasis in non-HIV patients.Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients.Interleukin-27 Early Impacts Leishmania infantum Infection in Mice and Correlates with Active Visceral Disease in Humans.Atypical presentation in adults in the largest community outbreak of leishmaniasis in Europe (Fuenlabrada, Spain).Travelers' Diarrhea in Children at Risk: An Observational Study From a Spanish Database.Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients.Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic.Diagnosis of bacteraemia and growth times.Glomerulonephritis and cryoglobulinemia: first manifestation of visceral leishmaniasis.Spatial distribution and cluster analysis of a leishmaniasis outbreak in the south-western Madrid region, Spain, September 2009 to April 2013.Erratum to: Imported malaria including HIV and pregnant woman risk groups: overview of the case of a Spanish city 2004-2014.Correction: Epidemiological Changes in Leishmaniasis in Spain According to Hospitalization-Based Records, 1997-2011: Raising Awareness towards Leishmaniasis in Non-HIV Patients.Cellular Markers of Active Disease and Cure in Different Forms of -Induced DiseaseAsymptomatic immune responders to Leishmania among HIV positive patients.[Chylothorax as a late complication of pacemaker endocarditis][Analysis of prognostic factors for mortality in bacteremia and fungemia at a university hospital. Experience of 10 years]Periannular extension of infective endocarditisRisk of embolization after institution of antibiotic therapy for infective endocarditis[Comparative study of prognostic and risk factors for mortality in polymicrobial bacteremia-fungemia in a university hospital: development over 10 years][Venous thromboembolism in patients with HIV: A case series][Community outbreak of leishmaniasis in the southern area of the community of Madrid]Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context
P50
Q35165352-A0DF351B-7156-4C89-A5E3-D4D94ADB40B9Q35818931-03868D89-D34F-43D3-A7A6-2291837FEB6CQ37393798-BF84742B-5FF7-4C48-BF16-184D5BF0BC72Q39042404-CB07AFA8-BB4A-430D-8235-7935F4FF3570Q39479451-917D4C4A-7494-45A1-BE97-0A0C9F367CC6Q40479841-796949A5-F467-46E7-ACCE-04D3B2EC2114Q40644506-0D49DFC7-994E-48D8-99F1-D2FCD7AAE2B5Q40945460-E0631BC4-E829-4D2F-9CF3-E0CB1D42D7BFQ41534302-A15961C9-F847-44FF-B527-94C18C748E92Q42159452-4600AD50-68E9-42FA-91A3-535A4D4646E0Q42950422-0D596318-09FB-428F-A66C-F3C99E1BF0C4Q43085910-EA25EDF2-8124-43D0-A9A5-1578DDFC157DQ59335519-40F6C1D5-AA49-404F-841E-883276C7F1BBQ64971191-D7446F51-16A3-4413-A33D-F6AEF05D9222Q73446190-29510C85-A5FB-48D6-AA19-7EE5F68A4938Q73960302-2536DDF8-F013-4B3A-A9BB-9A32105706BBQ77846059-AEBE40AC-6DFA-4EA9-AC0C-2256605D8C64Q78032663-A0AE5EF5-B508-4645-879F-449CDF5620C5Q78499411-B54A7034-3FBD-4963-ACAC-FE30F0DB6008Q83512314-DD6D9DE6-5FFC-454D-B0C3-CEA9F83714B1Q84443680-BA059993-C182-41D7-A7EA-1286607F239BQ92152011-162D2119-CCC9-4D36-9627-8D557FFD322FQ93178963-A920EBC5-4FF6-4C90-8563-4B95593262D4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Juan Víctor San Martín
@ast
Juan Víctor San Martín
@en
Juan Víctor San Martín
@es
Juan Víctor San Martín
@nl
type
label
Juan Víctor San Martín
@ast
Juan Víctor San Martín
@en
Juan Víctor San Martín
@es
Juan Víctor San Martín
@nl
prefLabel
Juan Víctor San Martín
@ast
Juan Víctor San Martín
@en
Juan Víctor San Martín
@es
Juan Víctor San Martín
@nl
P108
P1153
P106
P1153
55846605800
6507069219
7003610946
7005656812
P21
P31
P496
0000-0003-4457-5124